SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-19-004044
Filing Date
2019-12-20
Accepted
2019-12-20 16:02:04
Documents
43
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cns_q3-20190930.htm 10-Q 334823
2 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER cns_ex3101.htm EX-31.1 6815
3 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER cns_ex3102.htm EX-31.2 6825
4 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER cns_ex3201.htm EX-32.1 3015
5 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER cns_ex3202.htm EX-32.2 3032
  Complete submission text file 0001683168-19-004044.txt   2007735

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cnsp-20190930.xml EX-101.INS 251595
7 XBRL SCHEMA FILE cnsp-20190930.xsd EX-101.SCH 23650
8 XBRL CALCULATION FILE cnsp-20190930_cal.xml EX-101.CAL 33017
9 XBRL DEFINITION FILE cnsp-20190930_def.xml EX-101.DEF 126328
10 XBRL LABEL FILE cnsp-20190930_lab.xml EX-101.LAB 200960
11 XBRL PRESENTATION FILE cnsp-20190930_pre.xml EX-101.PRE 179393
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185 X701
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39126 | Film No.: 191301120
SIC: 2834 Pharmaceutical Preparations